» Articles » PMID: 37530965

Efficacy and Safety of Vacuum-assisted Excision (VAE) of Fibroadenomas: Experience in a Tertiary Centre

Overview
Journal Radiol Med
Specialty Radiology
Date 2023 Aug 2
PMID 37530965
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the technical success and efficacy rates of US-guided percutaneous vacuum-assisted excision (VAE) of breast fibroadenomas, also assessing procedural complications and long-term patient satisfaction rates.

Materials And Methods: The institutional database of a tertiary breast cancer referral centre was retrospectively reviewed to retrieve all women with fibroadenomas who underwent US-guided VAE between May 2011 and September 2019. We subsequently included in this study all fibroadenomas with a maximum diameter of 3 cm at US and an available histological confirmation obtained by core-needle biopsy before VAE. Immediately after VAE, technical success (defined as the correct VAE execution) and the occurrence of procedural complications were evaluated. Imaging follow-up (US ± mammography) after 6, 12, 24 and 36 months was performed to evaluate technical efficacy (defined as the absence of fibroadenoma recurrence at 6-month follow-up). Long-term patient satisfaction was evaluated with telephonic interviews in October 2022.

Results: We retrospectively included 108 women (median age 46 years) with 110 fibroadenomas diagnosed at core-needle biopsy with a median lesion size at US of 12 mm. Technical success was obtained in 110/110 VAEs (100%). Minor procedural complications (haematomas) occurred in 7/110 VAEs (6%), whereas 8/110 patients had a fibroadenoma recurrence at 6-month follow-up, resulting in a 93% technical efficacy (102/110 VAEs). All patients available for telephonic follow-up (104/104, 100%) reported high satisfaction with VAE results.

Conclusion: US-guided VAE is a safe and effective procedure for the excision of fibroadenomas, representing a viable alternative to surgery, with a low complication rate and high patient satisfaction.

Citing Articles

Single-port non-lipolytic endoscopic surgery via the axillary approach for the treatment of benign breast tumors has better clinical outcomes: a case control study.

Ma T, Cui J, Wang Q, Liu C, Wang B, Wang H BMC Womens Health. 2025; 25(1):26.

PMID: 39825383 PMC: 11740456. DOI: 10.1186/s12905-025-03563-z.


Effectiveness of ultrasound-guided vacuum-assisted excision for treating benign breast lesions.

Tan X, Xuhong J, Ai X, Niu Q, Liu J, Zhang Y Cancer Innov. 2024; 4(1):e158.

PMID: 39544723 PMC: 11560381. DOI: 10.1002/cai2.158.


Endoscopic resection of benign breast tumors via a single axillary incision using the insufflation method: a preliminary summary report.

Yang H, Yan G, Chen M, Xian J, Zhou W, Guan Z Updates Surg. 2024; 76(8):2933-2942.

PMID: 39212928 DOI: 10.1007/s13304-024-01972-7.

References
1.
Weaver M, Stuckey A . Benign Breast Disorders. Obstet Gynecol Clin North Am. 2022; 49(1):57-72. DOI: 10.1016/j.ogc.2021.11.003. View

2.
Lerwill M, Lee A, Tan P . Fibroepithelial tumours of the breast-a review. Virchows Arch. 2021; 480(1):45-63. DOI: 10.1007/s00428-021-03175-6. View

3.
Lee M, Soltanian H . Breast fibroadenomas in adolescents: current perspectives. Adolesc Health Med Ther. 2015; 6:159-63. PMC: 4562655. DOI: 10.2147/AHMT.S55833. View

4.
Roknsharifi S, Wattamwar K, Fishman M, Ward R, Ford K, Faintuch S . Image-guided Microinvasive Percutaneous Treatment of Breast Lesions: Where Do We Stand?. Radiographics. 2021; 41(4):945-966. DOI: 10.1148/rg.2021200156. View

5.
Neville G, Neill C, Murphy R, Corrigan M, Redmond P, Feeley L . Is excision biopsy of fibroadenomas based solely on size criteria warranted?. Breast J. 2018; 24(6):981-985. DOI: 10.1111/tbj.13069. View